Free Flow Electrophoresis (FFE) is a fractionation method, based on isoelectric focusing (IEF). We validate the reproducibility of the method and show that it can be applied by biobanks in order to efficiently and reproducibly fractionate fluid biospecimens and facilitate downstream proteomic applications. We also propose a simple method allowing to assess the reproducibility of each FFE run.
Introduction
Despite important advances in the use of genomics and transcriptomics for the identification of clinically relevant biomarkers, circulating proteins or peptides remain the most sought-after candidate biomarkers because of ease of blood sampling and biological meaningfulness. Their initial identification in biological fluids requires proteomic analysis, usually performed on well annotated fluid samples (e.g., serum, plasma) from biobanks.
One of the most important technical difficulties in this approach is linked to the dynamic range of plasma proteins which is of the order of magnitude of 10 10 (1). The most abundant protein in human plasma is serum albumin which is present at 40-50 mg/ml while some cytokines and tissue leakage proteins are present at levels approximating 10 pg/ml. To overcome this problem, two usual strategies are followed: depletion of high-abundance proteins and/or fractionation. Depletion of 2 albumin and IgG may increase sensitivity for detection of remaining proteins, but many proteins may get irreversibly and non-specifically bound during the process. Previous fractionation of the biological fluid is an alternative or can be combined to subsequent abundant-protein depletion. One of the least explored sample fractionation methods is FFE.
Free Flow Electrophoresis, first described by Hannig (2, 3) , is a prefractionation method enabling the resolution and identification of low abundant proteins and the reduction of protein mixture complexity. The method is performed with fractionation equipment that continuously streams a sample into a carrier ampholine solution flowing between two plates, as a thin laminar film (0. 3-1mm Immunosorbent Assay) and high throughput proteomic 2D-electrophoresis or mass spectrometry (4, 5, 6). However, in order for biobanks to be able to use FFE as a routine fluid biospecimen processing / fractionation method, it is important to confirm and be able to assess the reproducibility of the method in terms of pH gradient and consequently, protein contents in each fraction or pool of fractions obtained.
Reproducibility of 2D FFE-IEF/RP-HPLC (Reversed-Phase High-Performance Liquid Chromatography) system has previously been studied (7) . In that study, reproducibility was assessed from the downstream analysis point of view : RP-HPLC chromatograms, where Standard Deviation (SD) of retention times and of microplate well numbers were calculated across three replicates for nine peaks located between wells 13 and 87. The SD for uncorrected FFE well numbers was 0.83 (when the FFE well numbers were adjusted by pH, the SD was 0.62). This corresponds to 0.05pH units within FFE pools. However, this study was performed with standard cellular protein preparations. The objectives of our study were to assess the reproducibility of FFE in human plasma samples, and to identify internal quality control markers that can be used to define acceptance criteria for FFE fractionation reproducibility. Therefore, we validated the reproducibility of FFE fractionation of human serum and plasma, by showing that the position of proteins in a given range in a 96-well plate can be reliably predicted, enabling post-fractionation protein analysis.
Materials and Methods

FFE
FFE was applied as previously described (8, 9, 10 Validation of the method reproducibility: Five FFE separations in 6M urea, pH3-10
Five plasma aliquots from the same sample (plasma A) were used for the five separations to test the technical reproducibility in denaturing conditions. One aliquot of a second sample (plasma B) was used to test the biological reproducibility. The five separations were performed on five different days with all buffers freshly prepared. The microplates containing the FFE fractions were stored at -80°C for further analysis. Two serum aliquots were also used on two different days in the same separation conditions to compare plasma to serum fractionation profiles. One plasma aliquot was run in 8M
urea denaturing conditions to test for robustness of the method to composition of the separation buffer.
Electrophoretic analysis of FFE fractions
Serum and plasma FFE microplate contents were electrophoretically analysed with the Agilent 2100
Bioanalyzer in order to detect marker peaks for assessment of FFE fractionation reproducibility. The
Agilent Protein 230 Kit (in denaturating conditions) was used for the electrophoresis of the fractions according to the manufacturer's instructions. Preliminary analyses of microplate fractions showed that the most abundant protein, presumably corresponding to albumin, was detected in at least two fractions in the fraction range 4F-5G. Therefore, for each of the five separations, the microplate fractions 4F to 5G were analysed on the same chip. Collected electrophoretic data revealed six markers, each of which corresponded to a specific molecular weight and isoelectric point. For each of these protein markers, detected by Agilent electrophoresis in the fractions 4F to 5G, data including the molecular weight in kDa, the relative concentrations in ng/µl and the percentage of total protein were analyzed. The total relative concentrations of each fraction were also measured. Two different calculations were made, with or without alignment to the fraction with the highest protein concentration (presumably albumin).
Identification of internal QC protein markers FFE separations of two plasma and two serum 96-well microplates were used for pooling and
Western blotting (Wb) analysis. For each plate, three pool series were prepared: Pool 1 (wells 4F, 4G, 4H, 5A), pool 2 (wells 5B, 5C, 5D 5E), pool 3 (wells 5D, 5E, 5F, 5G). Each pool was made up of identical volumes of fractions from each individual well and stored at -20°C. Positive controls were prepared of plasma and serum extracted from fresh blood tubes after centrifugation at 2000g for 10 min at room temperature and supernatant dilution with PBS 1X (1/500 and 1/100 dilution for serum and plasma respectively).
SDS-PAGE
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed using the Signaling Technology, 3350S (1/500). Membranes were incubated overnight at 18-22°C room temperature (RT), three 10 minutes washing steps were made in TBS1x/Tween 0.05%. Secondary antibodies used were anti-mouse IgG, Horseradish peroxidase-linked, NA931 (1/5000), and antirabbit IgG, Horseradish peroxidase-linked, NA934 (1/25000). These were diluted in TBS1x/Tween 0.05% and incubated for 1h at RT, followed by three 10 minutes washing steps. Membranes were finally incubated in detection reagent (ECL plus Western blotting detection System) for 5 minutes and detection was performed using the ImageQuant TM LAS 4000 (GE Healthcare).
Results
FFE performance tests
The QC1 results for each separation showed three distinct peaks of approximately the same width, 14 to 17 wells, which correspond to successful Stripe tests according to the manufacturer's guide ( Figure 1, Figure 2 ). The QC2 results also showed successful results, with seven distinct peaks corresponding to markers of specific pI (data not shown). The gradient indicated by the distribution of the pI markers of the QC2 tests, was approximately pH 5 for fractions 4F to 5G, which were analysed with the Agilent system. The pH of all FFE buffers was stable across different preparations and separation days with separation buffers 1, 2 and 3 having pH 4, 7 and 9 respectively (Figure 3 ). Microwell fractions were analyzed based on our hypothesis that the fractions 4F to 5G can be grouped into three pools, each containing two of the six reproducible markers indicated by Agilent Bioanalyzer ( Figure 5 ). Western Blot results confirmed our hypothesis.
Variation in the molecular weights of the markers may be attributed to different post-translational modifications and/or different pre-processed status of the same protein.
All of the proposed internal quality control markers were reproducibly detected in their corresponding fraction pools, with the exception of the 58 and 93 kDa markers which were absent in the 20090805 microplate. This might be due to a relatively higher flow rate of the media pump on the day of this fractionation ( Figure 9 ).
Whereas one single~60kDa form was detected for albumin, and found predominantly in pool 2, different MW forms than the expected ones were observed for the other proteins. Protein preprocessed forms may explain these different molecular weight (MW) forms observed on Western blots.
Apolipoprotein A-I may aggregate with other lipid components of HDL (11, 12) . Pool 1 contained the expected, lower MW apolipoprotein A-I in higher concentrations than pool 2 and 3. This might be due to free apolipoprotein A-I being eluted into pool 1 wells whereas lipid-aggregated apoA-I is eluted into other pools. This finding proves that plasma and serum fractionation by FFE is efficient and could, for example, be used for apolipoprotein A-I purification.
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In ceruloplasmin Western blots, a band over 220 kDa was observed. This might be due to ceruloplasmin (122 kDa) binding to myeloperoxidase (MPO) (140 kDa) (13) . Furthermore, ceruloplasmin auto-aggregation has previously been observed (14) . Pool 1 contained a 150kDa and the >220kDa forms, pool 2 contained the 150kDa and a lower 60kDa form while pool 3 contained only the lower 60kDa form. Ceruloplasmin contains a number of potential glycosylation sites and this may explain the higher molecular weight form of 150kDa. The lower MW form may correspond to ceruloplasmin fragments.
Alpha-1-antitrypsin was expected to be found in higher concentrations in pool 3 than in pool 1 and 2 but this was not the case. Monomeric alpha-1-antitrypsin was detected in pool 3 but higher MW forms were also detected in pools 1 and 2. Residual binding of alpha-1 antitrypsin (52 kDa) to serine proteinases (66-75 kDa) (15) may be at the origin of the higher alpha-1 antitrypsin molecular weight bands, observed in pool 1 and 2.
Free-flow electrophoresis shows powerful pre-fractionation capacities enabling fast and accurate analysis of a given protein mixture from a biological fluid specimen, compared to chromatography or isotachophoresis. We showed that the FFE fractions are obtained following a reproducible separation scheme. Fractionation reproducibility could be confirmed, not at a single fraction level, but at a fourfraction pool level. We propose a simple internal QC method to assess reproducibility of fractionation; this is Western Blotting detection of apolipoprotein A-I and/or ceruloplasmin in fraction pool 4F-5A, albumin in fraction pool 5B-5E and alpha-1 antitrypsin in fraction pool 5D-5G.
Confirmation of the reproducibility of the fractionation pattern, allows the biobank to sub-collect, store and distribute specific FFE fractions or fraction pools. Plasma separation in 6M and 8M urea separation buffer. Total protein distribution across fractions shows the same pattern.
Figure 5
Validation hypothesis based on 6 protein markers separated in 3 different microwell pools 4F  4G  4H  5A  5B  5C  5D  5E  5F  5G 23 kDa = pI~5 154kDa= pI~5,2 64 kDa = pI~5,6 119kDa = pI~5,1 58kDa = pI~5,3 93kDa = pI~5,3
Figure 6
Total protein concentrations (A) and distribution of each of the internal QC protein markers in microwells 4F to 5G (B, C, D, E, F). Average and standard deviation of concentration in ng/l is shown for each of the five plasma A separations. Concentration in ng/l is shown for plasma B separation.
Well numbers were not adjusted by highest protein concentration fraction.
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